These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6770858)

  • 21. Physical interactions of isomeric benzo [a] pyrene diol-epoxides with DNA.
    MacLeod MC; Selkirk JK
    Carcinogenesis; 1982; 3(3):287-92. PubMed ID: 6805974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
    Buening MK; Wislocki PG; Levin W; Yagi H; Thakker DR; Akagi H; Koreeda M; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5358-61. PubMed ID: 281685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of stability of 7 beta,8 alpha-dihyroxy-9 alpha epoxybenzo(a)pyrene by complex formation with serum albumin.
    Roche CJ; Zinger D; Geacintov NE; Harvey RG
    Cancer Biochem Biophys; 1985 Jun; 8(1):35-40. PubMed ID: 3928138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse.
    Chang RL; Huang MT; Wood AW; Wong CQ; Newmark HL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Carcinogenesis; 1985 Aug; 6(8):1127-33. PubMed ID: 3926336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific carcinogen binding to DNA.
    Boles TC; Hogan ME
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5623-7. PubMed ID: 6435118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of the inhibition of mutagenicity of a benzo[a]pyrene 7,8-diol 9,10-epoxide by riboflavin 5'-phosphate.
    Wood AW; Sayer JM; Newmark HL; Yagi H; Michaud DP; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5122-6. PubMed ID: 6813854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the binding of stereoisomeric benzo(a)pyrene-7,8-diol-9,10-epoxides to histones in rat liver nuclei.
    Kurokawa M; MacLeod MC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5741-5. PubMed ID: 3931908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential binding of benzo[a]pyrene diol epoxide to the linker DNA of human foreskin fibroblasts in S phase in the presence of benzamide.
    Kurian P; Jeffrey AM; Milo GE
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2769-73. PubMed ID: 3921965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of the metabolism of benzo(a)pyrene to phenols, dihydrodiols, and quinones by high-pressure chromatography compared to analysis by aryl hydrocarbon hydroxylase assay, and the effect of enzyme induction.
    Yang SK; Selkirk JK; Plotkin EV; Gelboin HV
    Cancer Res; 1975 Dec; 35(12):3642-50. PubMed ID: 1192425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological detection of carcinogen-modified DNA fragments after in vivo modification of cellular and viral chromatin.
    Seidman M; Mizusawa H; Slor H; Bustin M
    Cancer Res; 1983 Feb; 43(2):743-8. PubMed ID: 6293703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fate of SV40 DNA in infected cells after treatment with benzo(a)pyrene diol epoxide.
    Chang GT; Harvey RG; Weiss SB
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1337-46. PubMed ID: 6268087
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene.
    Amin S; Desai D; Dai W; Harvey RG; Hecht SS
    Carcinogenesis; 1995 Nov; 16(11):2813-7. PubMed ID: 7586203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumorigenicity of the diastereomeric bay-region benzo(e)pyrene 9,10-diol-11,12-epoxides in newborn mice.
    Chang RL; Levin W; Wood AW; Lehr RE; Kumar S; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1981 Mar; 41(3):915-8. PubMed ID: 7459878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of hydrolysis to tetraols and binding of benzo(a)pyrene-7,8-dihydrodiol-9, 10-oxide and its tetraol derivatives to DNA. Conformation of adducts.
    Geacintov NE; Ibanez V; Gagliano AG; Yoshida H; Harvey RG
    Biochem Biophys Res Commun; 1980 Feb; 92(4):1335-42. PubMed ID: 6768360
    [No Abstract]   [Full Text] [Related]  

  • 37. Benzo(a)pyrene diolepoxide-DNA adducts detected by synchronous fluorescence spectrophotometry.
    Vahakangas K; Trivers G; Rowe M; Harris CC
    Environ Health Perspect; 1985 Oct; 62():101-4. PubMed ID: 3936704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzo[a]pyrene--DNA adduct formation in target cells in a cell-mediated mutation assay.
    Sebti SM; Baird WM; Knowles BB; Diamond L
    Carcinogenesis; 1982; 3(11):1317-20. PubMed ID: 6817937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of the 11,12-diol as a metabolite of benzo(a)pyrene by rat skin in vivo.
    Weston A; Grover PL; Sims P
    Biochem Biophys Res Commun; 1982 Apr; 105(3):935-41. PubMed ID: 6284170
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-diol epoxide of benzo[a]pyrene induces transient Mdm2 and p53 Ser15 phosphorylation, while anti-diol epoxide of dibenzo[a,l]pyrene induces a nontransient p53 Ser15 phosphorylation.
    Pääjärvi G; Jernström B; Seidel A; Stenius U
    Mol Carcinog; 2008 Apr; 47(4):301-9. PubMed ID: 17932951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.